Hirotaka Motoyama
Niigata University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hirotaka Motoyama.
European Journal of Gastroenterology & Hepatology | 2002
Masaaki Natsui; Rintaro Narisawa; Hirotaka Motoyama; Shun-ichi Hayashi; Keiichi Seki; Hiroto Wakabayashi; Shinichi Itoh; Hitoshi Asakura
Objective There are a number of views on the indication for endoscopic papillary balloon dilation (EPBD) in the management of bile duct stones. In this study, we have evaluated the efficacy and safety of EPBD compared with endoscopic sphincterotomy (EST). Design Prospective randomized trial. Setting One university hospital and one general hospital. Participants and main outcome measures One hundred and forty patients were randomly allocated to EPBD or EST. Outcomes and complications were observed for a median period of 30 months. Results Both treatment approaches finally achieved similar success rates and needed similar numbers of treatment sessions for patients with stones less than 10 mm in diameter. However, for patients with stones of 10 mm or more, EPBD required a significantly greater mean number of treatment sessions than EST (2.4 vs 1.6, P < 0.01). Early complications occurred in seven EPBD (four pancreatitis, two cholangitis and one basket impaction) and eight EST (three pancreatitis, two bleeding and three cholangitis) patients. Late complications occurred in four EPBD (three recurrent bile duct stones and one cholecystitis) and six EST (three recurrent stones and three cholecystitis) patients. Conclusions EPBD has little risk of bleeding. The technique removed small bile duct stones just as easily as did EST. These two procedures had approximately the same risk of pancreatitis and incidence of recurrent bile duct stones. Therefore, both procedures appear to be appropriate treatments for small bile duct stones. Whether or not EPBD becomes an established treatment will depend on further long-term studies.
Digestive Diseases and Sciences | 2002
Yuichi Sato; Mitsuya Iwafuchi; Jun-ichi Ueki; Akira Yoshimura; Tsutomu Mochizuki; Hirotaka Motoyama; Kazuhito Sugimura; Terasu Honma; Rintaro Narisawa; Takafumi Ichida; Hitoshi Asakura; David H. Van Thiel
In Japan, most cases of gastric carcinoid tumor (GCT) are unassociated with either autoimmune gastritis (AIG) showing type-A chronic atrophic gastritis (CAG-A) or Zollinger-Ellison syndrome (ZES). However, the pathogenesis of this tumor remains unknown. Recent studies have determined that Helicobacter pylori infection induces gastric carcinoid in Mongolian gerbils and that H. pylori lipopolysaccharide exerts a mitogenic effect on ECL cells. We examined five patients with histologically diagnosed GCT, 40 patients with H. pylori-positive gastric ulcer (Hp+GU), 24 patients with H. pylori-positive duodenal ulcer (Hp+DU), and 12 patients with AIG showing CAG-A topographically. We compared the prevalence of H. pylori infection, and the levels of gastrin and pepsinogen (PG) in the serum of patients with GCT with those of patients with Hp+GU, or Hp+DU, and AIG. We also investigated the histological characteristics of the tumor and the gastric corpus mucosa in the GCT patients. The levels of serum gastrin and PG I and II were measured using an RIA kit. In all five (100%) patients with GCT, H. pylori infection was present, without any evidence of AIG or ZES. The serum levels of gastrin in the GCT patients were higher than those in either Hp+GU or Hp+DU patients and lower than those in the AIG patients. In contrast, serum PG I levels and the PG I/II ratio were lower in the GCT group than in the Hp+GU or Hp+DU groups. Histologically, all GCTs were ECL cell tumors and peritumoral corporal mucosal atrophy was observed in four of the five patients with GCT. In conclusions, H. pylori infection and hypergastrinemia were found in the patients with GCT without AIG. This finding suggests that H. pylori infection may induce corporal mucosal atrophy and hypergastrinemia that can produce a GCT with time.
Archive | 2002
Takashi Kuroiwa; Takeshi Suda; Toru Takahashi; Haruka Hirono; Masaaki Natsui; Hirotaka Motoyama; Minoru Nomoto; Yutaka Aoyagi
In the case reported here, the characteristic features of AIP were evaluated by ultrasonography, computed tomography and endoscopic retrograde cholangiopancreatography, initially in the intrahepatic- and extrahepatic bile ducts, and later in the pancreas. In addition, histological examination revealed lymphocytic sclerosis around the intralobular bile ducts, as is reported in AIP, without chronic nonsuppurative destructive cholangitis or onion-skin-like appearance. Immunohistochemistry identified the infiltrating lymphocytes as T cells. Although hypergammaglobulinemia was observed with elevation of hepatobiliary and pancreatic enzymes, no other serological or physiological abnormalities suggestive of other systemic autoimmune diseases were detected. These findings progressed over a three-month period and were dramatically resolved within one month by steroid therapy. These observations support a novel clinical entity characterized by the presence of bile duct lesions similar to the pancreatic involvement seen in AIP that is distinct pathophysiologically, histologically, and therapeutically from the so-called autoimmune cholangitis or primary sclerosing cholangitis.
Digestive Endoscopy | 2001
Kazuhiro Funakoshi; Nobuhiro Akiyama; Ikuo Kozakai; Futoshi Arai; Hirotaka Motoyama; Toshiyuki Kato; Kazuei Ogoshi; Tamaki Ohta
A case of successful endoscopic therapy of superficial esophageal cancer on varices in a patient with alcoholic liver cirrhosis is reported. A slightly depressed superficial cancer (type 0‐IIc) occupied half the inner surface of the middle esophagus. Endoscopic ultrasonography revealed esophageal varices and periesophageal collaterals, but no perforating veins connecting the varices and collaterals were observed where the cancer was located. The esophageal cancer could not be detected even with a 20 MHz microprobe. The tortuous esophageal varices in the lower esophagus were endoscopically ligated to reduce blood flow just below the cancer and 10 mL polidocanol solution was endoscopically injected to induce sclerosis of the varices. After these procedures, the mucosal cancer was endoscopically resected without any severe complications and residual cancer was eliminated by cauterization using a heater probe. Histopathological examination revealed that poorly differentiated squamous cell carcinoma invaded into the lamina propria mucosae but not into the vessels or the lymphatic system. Three years after treatment, the patient showed no signs of local recurrence of cancer. It is considered that the endoscopic techniques used in this patient constitute a valuable and minimally invasive treatment for superficial esophageal cancer on varices.
Clinical Cancer Research | 2001
Keiichi Seki; Takeshi Suda; Yutaka Aoyagi; Satoshi Sugawara; Masaaki Natsui; Hirotaka Motoyama; Yoshio Shirai; Teruo Sekine; Hirokazu Kawai; Yusaku Mita; Nobuo Waguri; Takashi Kuroiwa; Masato Igarashi; Hitoshi Asakura
Journal of Pediatric Surgery | 2000
Yasushi Iinuma; Rintaro Narisawa; Makoto Iwafuchi; Masanori Uchiyama; Masafumi Naito; Minoru Yagi; Satoshi Kanada; Masahiro Otaki; Satoru Yamazaki; Terasu Honma; Hirotaka Motoyama; Yasuyuki Baba
Digestive Diseases and Sciences | 2002
Takashi Kuroiwa; Takeshi Suda; Toru Takahashi; Haruka Hirono; Masaaki Natsui; Hirotaka Motoyama; Minoru Nomoto; Yutaka Aoyagi
Acta Gastro-Enterologica Belgica | 2006
Hirotaka Motoyama; Takashi Yamamoto; Nobuhiro Akiyama; Jun Inayoshi; Futoshi Arai; Kazuhiro Funakoshi; Toshiyuki Kato; Tamaki Ohta; Yuduru Maruyama
Gastroenterology | 2000
Yuichi Sato; Akira Yoshimura; Tsutomu Mochizuki; Hirotaka Motoyama; Kazuhito Sugimura; Terasu Honma; Rintaro Narisawa; Hitoshi Asakura; Jun-ichi Ueki
Digestive Endoscopy | 2000
Hirotaka Motoyama; Jun-ichi Ueki; Yasuyuki Baba; Hitoshi Asakura